A xanthomatosis-susceptibility gene may exist in a Syrian family with familial hypercholesterolemia

European Journal of Human Genetics

Volumn 5, Issue 5, 1997, Pages 315-323

  Vergopoulos, Athhanasios ^a   Bajari, Tarek ^a   Jouma, Muhidien ^b   Knoblauch, Hans ^c   Aydin, Atakan ^a   Bähring, Sylvia ^a   Mueller Myhsok, Bertram ^c   Dresel, Alois ^a   Joubran, Rana ^b   Luft, Friedrich C ^a,d   Schuster, Herbert ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b DAMASCUS UNIVERSITY   (Syrian Arab Republic)

^c UNIVERSITY OF HAMBURG   (Germany)

^d Franz Volhard Klinik   (Germany)

Author keywords

Familial hypercholesterolemia; Genetics; Giant xanthomas; Low density lipoprotein receptor mutations; Xanthomatosis

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONSANGUINITY; DNA DETERMINATION; DNA SEQUENCE; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY; FEMALE; GENE; GENE MUTATION; GENE SEGREGATION; GENETIC SUSCEPTIBILITY; HOMOZYGOTE; HUMAN; HUMAN CELL; HYPOTHESIS; MALE; POINT MUTATION; PRIORITY JOURNAL; RECEPTOR GENE; SYRIAN ARAB REPUBLIC; XANTHOMATOSIS;

EID: 12644288348     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1159/000484783     Document Type: Article

References (23)

1. Khachadurian AK: The inheritance of essential familial hypercholesterolemia. Am J Med 1964;37:402-407.
2. Kwiterovich PO, Fredrickson DS, Levy RI: Familial hypercholesterolemia (one form of familial hyperlipoproteinemia): A study of its biochemical, genetic, and clinical presentation in childhood. J Clin Invest 1974;53:1237-1249.
3. Brown MS, Goldstein JL: Familial hypercholesterolemia: Genetic, biochemical and pathophysiologic considerations. Adv Intern Med 1975;20:273-296.
4. Goldstein JL, Brown MS: Familial hypercholesterolemia: Pathogenesis of a receptor disease. Johns Hopkins Med J 1978;143:8-16.
5. Hata Y, Shigematsu H, Tushima M, Oikawa T, Yamamoto M, Yamauchi Y, Hirose N: Serum lipid and lipoprotein profiles in patients with xanthomas: A correlative study on xanthoma and atherosclerosis. Jpn Circ J 1981;45:1236-1242.
6. Day IN, Haddad L, O'Dell SD, Day LB, Whittall RA, Humphries SE: Identification of a common low density lipoprotein receptor mutation (R329X) in the south of England: Complete linkage disequilibrium with an allele of microsatellite D19S394. J Med Genet 1997;34: 111-116.
7. Haliassos A, Chomel JC, Grandjouan S, Kruh J, Kaplan JC, Kitzis A: Detection of minority point mutations by modified PCR technique: A new approach for a sensitive diagnosis of tumor-progression markers. Nucleic Acids Res 1989;17:8093-8098.
8. Morton NE, Rao DC, Lalouel J-M: Methods in Genetic Epidemiology. Basel, Karger, 1983.
9. Hobbs HH, Brown MS, Goldstein JL: Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992;1: 445-466.
10. Hobbs HH, Russell DW, Brown MS, Goldstein JL: The LDL receptor locus and familial hypercholesterolemia: Mutation analysis of a membrane protein. Annu Rev Genet 1990;24:133-170.
11. Lehrman MA, Schneider WJ, Brown MS, Davis CG, Elhammer A, Russel DW, Goldstein JL: The Lebanese allele at the LDL receptor locus. Nonsense mutation produces truncated receptor that is retained in endoplasmic reticulum. J Biol Chem 1987;262:401-410.
12. Leitersdorf E, Tobin EJ, Davignon J, Hobbs HH: Common low-density lipoprotein receptor mutations in the French Canadian population. J Clin Invest 1990;85:1014-1023.
13. Thannhauser SJ, Magentantz H: The different clinical groups of xanthomatous disease: A clinical physiological study of 22 cases. Ann Intern Med 1937;11:1662-1669.
14. Buja LM, Kovanen PT, Bilheimer DW: Cellular pathology of homozygous familial hypercholesterolemia. Am J Pathol 1979;97:327-358.
15. Bhattacharyya AK, Connor WE, Mausolf FA, Flatt AE. Turnover of xanthoma cholesterol in hyperlipoproteinemia patients. J Lab Clin Med 1976;87:503-518.
16. Sugiyama N, Marcovina S, Gown AM, Seftel H, Joffe B, Chait A: Immunohistochemical distribution of lipoprotein epitopes in xanthomata from patients with familial hypercholesterolemia. Am J Pathol 1992;141:99-106.
17. Yamamoto A, Hara H, Takaichi S, Wakasugi J-I, Tomikawa M: Effect of probucol on macrophages, leading to regression of xanthomas and atheromatous vascular lesions. Am J Cardiol 1988;62:31B-36B.
18. Kajinami K, Nishitsuji M, Takeda Y, Shimizu M, Koizumi J, Mabuchi H: Long-term probucol treatment results in regression of xanthomas, but in progression of coronary atherosclerosis in a heterozygous patient with familial hypercholesterolemia. Atherosclerosis 1996; 230:181-187.
19. Ross R: The pathogenesis of atherosclerosis - an update. N Engl J Med 1986;314:488-500.
20. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: Modification of low-density lipoprotein that increases its atherogenicity. N Engl J Med 1989;320: 915-924.
21. Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK: Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 1994; 93:1885-1893.
22. van Ree JH, Gijbels MJJ, van den Broek WJAA, Hofker MH, Havekes LM: Atypical xanthomatosis in apolipoprotein E-deficient mice after cholesterol feeding. Atherosclerosis 1995;112:237-243.
23. Krieger M: Molecular flypaper and atherosclerosis: structure of the macrophage scavenger receptor. Trends Biochem Sci 1992;17:141-146.